Fierce Pharma October 11, 2024
Nick Paul Taylor

A survey of more than 2,000 patients and physicians has painted a rosy picture of the impact of pharma ads, showing that promotions raise awareness of treatment options, drive discovery of health conditions and improve management of existing ailments.

The survey is the result of a collaboration between media intelligence business Magna and advertising platform DeepIntent. Together, the businesses ran online surveys of 1,166 patients and 1,001 doctors to determine whether pharma ads do more than just build brands. Advocates of direct-to-consumer ads argue they have educational value and improve health. The survey gathered data to support that view.

First, Magna and DeepIntent showed pharma ads do their primary job: raising awareness of treatments. Almost two-thirds of patients said they...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Physician, Provider, Survey / Study, Trends
Top 5 Obesity Articles of 2024
Geoffrey Hinton’s Prediction Of Human Extinction At The Hands Of AI
Why seed oils have become a target for RFK Jr. and health influencers
How to rebuild trust in health care and improve patient outcomes [PODCAST]
CMS Moved to Expand Obesity Drug Coverage. Private Insurers Need to Step Up.

Share This Article